ChemoCentryx, Inc.
ChemoCentryx, Inc. (CCXI) Stock Overview
Explore ChemoCentryx, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
0
P/E Ratio
-26.46
EPS (TTM)
$-2.00
ROE
-0.38%
CCXI Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ChemoCentryx, Inc. (CCXI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $13.58.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -26.46 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.